By MATTHEW PERRONE
U.S. health regulators on Wednesday sent warning letters to 18 websites selling counterfeit or unapproved versions of Botox and similar injectable drugs commonly used to smooth wrinkles.
Related Articles
California Republicans challenge Prop 50 in lawsuit, fight to block new maps
Judge in Comey case orders prosecutors to produce documents from investigation
Shipping delays expected after UPS cargo plane crash
Starbucks’ union workers plan strike next week unless company agrees to a contract
Texas Democrat Jasmine Crockett says she’s ‘seriously’ considering Senate run
The Food and Drug Administration said it was taking action after receiving reports of injuries in connection with the products, including toxic side effects.
Botox is a diluted, purified form of

The Baltimore Sun

Raw Story
Reuters US Business
RadarOnline
NBC4 Washington
Psychology Today
The Conversation
Cover Media
Verywell Health
Associated Press US News